Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; Depression; Lipophilic statins; HMG-CoA reductase inhibitors;
مقالات ISI مهار کننده های HMG-CoA ردوکتاز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده های HMG-CoA ردوکتاز; HMG-CoA reductase inhibitors; Racial disparities; Cholesterol treatment guidelines; Temporal trends; Diabetes;
Keywords: مهار کننده های HMG-CoA ردوکتاز; cardiac troponin; cardiovascular disease; HMG-CoA reductase inhibitors; myocyte toxicity; primary prevention;
Keywords: مهار کننده های HMG-CoA ردوکتاز; HMG-CoA reductase inhibitors; Prognosis; Renal cell carcinoma; Statins; Targeted therapy;
Keywords: مهار کننده های HMG-CoA ردوکتاز; pediatric heart transplantation; rejection; vasculopathy; statin; HMG-CoA reductase inhibitors; PTLD;
Keywords: مهار کننده های HMG-CoA ردوکتاز; 4; CABG; coronary artery bypass grafting; CPB; cardiopulmonary bypass; CRP; C-reactive protein; HMG-CoA reductase inhibitors; 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors; IL; interleukin; TNF; tumor necrosis factor;
Keywords: مهار کننده های HMG-CoA ردوکتاز; Gender; HMG-CoA reductase inhibitors; Ischemic heart disease; Lipid disorders/atherosclerosis; Risk factors;
Keywords: مهار کننده های HMG-CoA ردوکتاز; Drug utilization; Drug pricing; Health insurance reimbursement; Treatment costs; Statins; HMG-CoA reductase inhibitors;
Keywords: مهار کننده های HMG-CoA ردوکتاز; Pediatric lipid-lowering medications; HMG-CoA reductase inhibitors; Statins; Bile acid sequestrants; Fibric acid derivatives; Niacin; Ezetimibe; Omega-3 fatty acids
Keywords: مهار کننده های HMG-CoA ردوکتاز; HMG-COA reductase inhibitors; Statins Hypothyroidism; Statin intolerance; Dyslipidemia; Subclinical hypothyroidism; Statin rechallenge; Epidemiology;
Keywords: مهار کننده های HMG-CoA ردوکتاز; HMG-CoA reductase inhibitors; Statins; Mycetes; LDL receptors; Hypercholesterolemia; CYP450; OATP
Keywords: مهار کننده های HMG-CoA ردوکتاز; HMG-CoA reductase inhibitors; Statins; Chronic kidney disease; Cardiovascular outcomes; Renal outcomes; Kidney transplantation
Keywords: مهار کننده های HMG-CoA ردوکتاز; Diastolic function; Heart failure; HMG-CoA reductase inhibitors; Inflammation; Statins; MortalityCAD, coronary artery disease; CRP, C reactive protein; EF, ejection fraction; eNOS, endothelial NO synthase; ERK, extracellular-signal-regulated kinase; HF, h
Keywords: مهار کننده های HMG-CoA ردوکتاز; Insulin-like growth factor 1; IGF-1; Insulin-like growth factor binding protein 1; IGFBP-1; Statins; HMG-CoA reductase inhibitors; Type 1 diabetes; Microcirculation
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; HMG-CoA reductase inhibitors; Drug-related side effects; Statin intolerance; Myotoxicity; MyopathyEstatinas; Inhibidores de la HMG-CoA reductasa; Efectos secundarios a fármacos; Intolerancia a estatinas; Miotoxicidad; Miopatía
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; HMG-CoA reductase inhibitors; Drug-related side effects; Statin intolerance; Myotoxicity; MyopathyEstatinas; Inhibidores de la HMG-CoA reductasa; Efectos secundarios a fármacos; Intolerancia a estatinas; Miotoxicidad; Miopatía
Statin Use Is Associated With a Lower Risk of TB
Keywords: مهار کننده های HMG-CoA ردوکتاز; HMG-CoA reductase inhibitors; statin; tuberculosis; cDDD; cumulative defined daily dose; HR; hazard ratio; ICD-9-CM; International Classification of Diseases, 9th Revision, Clinical Modification; NHI; National Health Insurance; NHIRD; National Health Insu
Critical review of statins: A bio-analytical perspective for therapeutic drug monitoring
Keywords: مهار کننده های HMG-CoA ردوکتاز; Bio-analytical techniques; Statins; HMG-CoA reductase inhibitors; Review; Sample extraction; Biological fluids; Therapeutic drug monitoring;
Coenzyme Q10 remarkably improves the bio-energetic function of rat liver mitochondria treated with statins
Keywords: مهار کننده های HMG-CoA ردوکتاز; Coenzyme Q10; Atorvastatin; Simvastatin; Mitotoxicity; HFD (high fat diet); HMG-CoA reductase inhibitors;
Vitamin D status modifies the association between statin use and musculoskeletal pain: A population based study
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; HMG-CoA reductase inhibitors; Vitamin D; 25-Hydroxyvitamin D; Myalgia; Muscle symptoms; Statin intolerance;
Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial
Keywords: مهار کننده های HMG-CoA ردوکتاز; Ezetimibe; HMG-CoA reductase inhibitors; Plaque; Intravascular ultrasound
“Observational Medicine” should be replaced by “Real Science”
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; HMG-CoA reductase inhibitors; EECP; Enhanced Extracorporeal Counterpulsation; ACEI; angiotensin-converting-enzyme inhibitor;
Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors
Keywords: مهار کننده های HMG-CoA ردوکتاز; Nifedipine; HMG-CoA reductase inhibitors; Pharmacokinetics; P-gp; CYP3A4
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention : The Multicenter Randomized Controlled PRECISE-IVUS Trial
Keywords: مهار کننده های HMG-CoA ردوکتاز; HMG-CoA reductase inhibitors; intravascular ultrasoundACC, American College of Cardiology; ACS, acute coronary syndrome(s); AHA, American Heart Association; CAD, coronary artery disease; CSA, cross-sectional area; CV, cardiovascular; EEM, external elastic
Stereoselective synthesis of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
Keywords: مهار کننده های HMG-CoA ردوکتاز; HMG-CoA reductase inhibitors; Statins; Chiral β-hydroxy-δ-lactone; Chiral 3,5-syn-diol acid; Asymmetric synthesis; Ac; acetyl; Ar; aryl; Bn; benzyl; Bz; benzoyl; n-Bu; butyl; t-Bu; tert-butyl; CDI; 1,1â²-carbonyldiimidazole; BINOL; 1,1â²-bi-2-naphthol
HMG-CoA reductase inhibitors (statins) and bone mineral density: A meta-analysis
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; HMG-CoA reductase inhibitors; Bone mineral density; Meta-analysis;
Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statin; Statin-induced myopathy; Mitochondrial DNA; Mitochondria; HMG-CoA reductase inhibitors; Skeletal muscle;
Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy
Keywords: مهار کننده های HMG-CoA ردوکتاز; Prostate cancer; Recurrence; Statins; HMG-CoA reductase inhibitors; Radiation thearpy
Lipid control in patients with coronary heart disease treated in primary care or cardiology clinics
Keywords: مهار کننده های HMG-CoA ردوکتاز; Cholesterol; Coronary disease; HMG-CoA reductase inhibitors; Primary health care; Secondary prevention; Guideline adherence
Differences in cholesterol management among states in relation to health insurance and race/ethnicity across the United States
Keywords: مهار کننده های HMG-CoA ردوکتاز; Cholesterol screening; Ethnicity; Health insurance; HMG-CoA reductase inhibitors; Lipid lowering medications; Race
Relationship among low cholesterol levels, depressive symptoms, aggression, hostility, and cynicism
Keywords: مهار کننده های HMG-CoA ردوکتاز; Aggression; Cholesterol; Cynicism; Depression; Epidemiology; HMG-CoA reductase inhibitors; Hostility
Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
Keywords: مهار کننده های HMG-CoA ردوکتاز; Esophageal Cancer Risk; Cholesterol-Lowering Drugs; HMG-CoA Reductase Inhibitors; Chemoprevention; BE; Barrett's esophagus; CI; confidence interval; EAC; esophageal adenocarcinoma; EC; esophageal cancer; ESCC; esophageal squamous cell cancer; HGD; high-gr
Chronic administration of atorvastatin induced anti-convulsant effects in mice: The role of nitric oxide
Keywords: مهار کننده های HMG-CoA ردوکتاز; Atorvastatin; HMG-CoA reductase inhibitors; Convulsion; Seizure; Nitric oxide; Mice
Pediatric Pharmacogenomics
Keywords: مهار کننده های HMG-CoA ردوکتاز; Pharmacogenomics; Ontogeny; HMG-CoA reductase inhibitors; Statins; Low-density lipoprotein cholesterol; OATP1B1; Cytochrome P450; Pediatrics;
Atorvastatin affects the tissue concentration of hydrogen sulfide inmouse kidneys and other organs**
Keywords: مهار کننده های HMG-CoA ردوکتاز; hydrogen sulfide; statins; HMG-CoA reductase inhibitors; kidney; mouse
Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy
Keywords: مهار کننده های HMG-CoA ردوکتاز; Diabetes; Nephropathy; Lipid peroxidation; Arylesterase; Lovastatin; HMG-CoA reductase inhibitors
The relationship of vitamin D deficiency to statin myopathy
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; Myopathy; Muscle; Skeletal muscle; HMG-CoA reductase inhibitors; Lipids; Vitamin D; Vitamin D deficiency
Statins and prostate cancer: Molecular and clinical aspects
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; HMG-CoA reductase inhibitors; Prostate cancer; PSA; Lipid rafts; Isoprenoids;
Novel mechanistic and clinical implications concerning the safety of statin discontinuation
Keywords: مهار کننده های HMG-CoA ردوکتاز; HMG-CoA reductase inhibitors; withdrawal; pleiotropic effects; mechanism
Pitavastatin Calcium: Clinical Review of a New Antihyperlipidemic Medication
Keywords: مهار کننده های HMG-CoA ردوکتاز; cholesterol; HMG-CoA reductase inhibitors; Livalo; low-density lipoprotein; pitavastatin; statins
Use of Statins in Adhesive Small Bowel Obstruction1
Keywords: مهار کننده های HMG-CoA ردوکتاز; adhesions; statin; HMG-CoA reductase inhibitors; bowel obstruction;
Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy
Keywords: مهار کننده های HMG-CoA ردوکتاز; Osteoprotegerin; RANK ligand; Diabetes; Nephropathy; HMG-CoA reductase inhibitors; Lovastatin
Prospective evaluation of the effect of statins on blood pressure control in hypertensive patients in clinical practise
Keywords: مهار کننده های HMG-CoA ردوکتاز; Hypertension; Hyperlipidemia; Statins; HMG-CoA reductase inhibitors; Influencing factors;
Evidence that Statins Protect Renal Function During Endovascular Repair of AAAs
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; HMG-CoA reductase inhibitors; Renal function; Abdominal aortic aneurysm; EndovascularAAA, Abdominal aortic aneurysm; EVAR, Endovascular aortic repair; SR, Suprarenal; IR, Infrarenal; SCr, Serum creatinine; CrCl, Creatinine clearance
The HMG-CoA Reductase Inhibitor Pravastatin Stimulates Insulin Secretion through Organic Anion Transporter Polypeptides
Keywords: مهار کننده های HMG-CoA ردوکتاز; SLCO (SLC21); SLC transporters; HMG-CoA reductase inhibitors; xenobiotics; diabetes; disease; insulin; endobiotics; adipose; organ; islet; OATP; SLC transporters
Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells
Keywords: مهار کننده های HMG-CoA ردوکتاز; caveolae; cyclic GMP; cytotoxicity; endothelial function; nitric oxide; HMG-CoA reductase inhibitors
The effect of statins on mortality from severe infections and sepsis: A systematic review and meta-analysis
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; HMG-CoA reductase inhibitors; Sepsis, infection; Bacteremia; Mortality;
Photostability of pitavastatin—A novel HMG-CoA reductase inhibitor
Keywords: مهار کننده های HMG-CoA ردوکتاز; Statins; HMG-CoA reductase inhibitors; Pitavastatin; Photostability; Photodegradation
Novel enzyme-linked immunosorbent assay for determination of fluvastatin in plasma at picogram level
Keywords: مهار کننده های HMG-CoA ردوکتاز; Atherosclerosis; HMG-CoA reductase inhibitors; Fluvastatin; ELISA
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Keywords: مهار کننده های HMG-CoA ردوکتاز; Hypercholesterolemia; Cardiovascular disease; Chronic kidney disease; HMG-CoA reductase inhibitors; Pravastatin